Senior Director, Computational Biology, large Pharma
“We have not seen anything like [QuartzBio] and it has the power to unlock this data for a variety of our stakeholders, such as medical directors and translational scientists, which is exciting.”
This author has not written his bio yet.
But we are proud to say that QuartzBio Team contributed 92 entries already.
“We have not seen anything like [QuartzBio] and it has the power to unlock this data for a variety of our stakeholders, such as medical directors and translational scientists, which is exciting.”
“QuartzBio’s reporting is very helpful. From an Operations perspective, it helps us identify sites that may be missing collections so we can have the study’s CRO mitigate”.
“The [QuartzBio] platform is a good investment. Think about the turnover. The platform allows continuity for programs, nothing is lost in transitions. Very valuable as central repository of data. When people leave companies – and they have been massaging the data – the data is basically lost – I have no idea where to find […]
We’re thrilled to be a Gold Sponsor at BiotechX USA, in Philadelphia this September 17-18 — the much-anticipated conference covering precision medicine and digital transformation in biopharmaceutical development. Will we see you there? Here’s a sneak peek at what you’ll experience when you demo QuartzBio’s AI-enabled Biomarker Intelligence Platform, powered by the first Precision Medicine LLM […]
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.
QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.
© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR
Web Design and Development by RainCastle Communications.